Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06439355

Single-center Study of Gustation in Idiopathic Parkinson's Disease and Lewy Body Disease Using Gustatory Evoked Potential Analysis

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
66 (estimated)
Sponsor
Centre Hospitalier Universitaire Dijon · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The aim of the PI-PEG study is to explore the taste functions of the following 3 groups of participants: * healthy volunteers * patients with early Parkinson's disease * patients with incipient Lewy body disease. To this end, the results obtained from taste evoked potentials in each of the 3 groups of participants will be compared with each other and with different nutritional, motor and cognitive data. This study could reveal a difference in cortical processing of gustatory sensory information between patients who have had idiopathic Parkinson's disease progressing for 3 years or less, and patients who have had Lewy body disease progressing for 3 years or less. Indeed, a modification of taste evoked potentials (in terms of latencies) proportional to the degree of cerebral degeneration could be observed.

Conditions

Interventions

TypeNameDescription
BIOLOGICALFasting blood testmetabolic assays determination of food intake hormones oxidative stress and neurodegeneration marker assays
OTHERSubject interviewsocio-demographic data, medical and family history, treatment taken
OTHERMotor assessmentMDS-UPDRS scale PART III
OTHERNeurocognitive assessmentMoCA and MMSE scales
OTHERNutritional assessmentanthropometric data (weight, height, BMI, waist circumference, hip circumference, android/gynoid ratio, triceps skin fold, brachial circumference), bioelectrical impedancemetry (fat mass, lean mass, water mass and bone mass)
OTHERTaste testsRecording of PEGs in response to a sucrose solution and a free fatty acid solution (prepared beforehand)

Timeline

Start date
2024-05-27
Primary completion
2026-05-01
Completion
2026-05-01
First posted
2024-06-03
Last updated
2024-06-07

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06439355. Inclusion in this directory is not an endorsement.